Suzanne J. Randle

2.4k total citations
20 papers, 1.1k citations indexed

About

Suzanne J. Randle is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Suzanne J. Randle has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Suzanne J. Randle's work include Ubiquitin and proteasome pathways (10 papers), Epigenetics and DNA Methylation (5 papers) and Autophagy in Disease and Therapy (5 papers). Suzanne J. Randle is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Epigenetics and DNA Methylation (5 papers) and Autophagy in Disease and Therapy (5 papers). Suzanne J. Randle collaborates with scholars based in United Kingdom, United States and Brazil. Suzanne J. Randle's co-authors include Heike Laman, David E. Nelson, Eileen McGowan, Dennis W. Dickson, Luisa Onstead, Robert Price, Lisa Smithson, Todd E. Golde, Craig Zwizinski and Jungsu Kim and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Nature Neuroscience.

In The Last Decade

Suzanne J. Randle

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne J. Randle United Kingdom 14 639 470 245 242 162 20 1.1k
Prasad Tammineni United States 15 675 1.1× 505 1.1× 126 0.5× 339 1.4× 157 1.0× 20 1.2k
Natura Myeku United States 11 581 0.9× 423 0.9× 136 0.6× 282 1.2× 175 1.1× 15 1.0k
Mario Nizzari Italy 20 958 1.5× 376 0.8× 110 0.4× 157 0.6× 352 2.2× 51 1.4k
Hyun Jin Cho South Korea 19 736 1.2× 414 0.9× 331 1.4× 95 0.4× 220 1.4× 27 1.4k
Misaki Sekiguchi Japan 11 531 0.8× 964 2.1× 143 0.6× 287 1.2× 272 1.7× 19 1.4k
Seung Jae Hyeon South Korea 18 495 0.8× 312 0.7× 221 0.9× 109 0.5× 152 0.9× 40 1.0k
Julie Dunys France 16 362 0.6× 457 1.0× 110 0.4× 148 0.6× 180 1.1× 22 816
Pierre Dourlen France 15 500 0.8× 299 0.6× 121 0.5× 171 0.7× 216 1.3× 23 924
Chengyuan Mao China 17 482 0.8× 255 0.5× 328 1.3× 84 0.3× 205 1.3× 60 1.1k
Heidi Martini‐Stoica United States 8 344 0.5× 390 0.8× 152 0.6× 443 1.8× 119 0.7× 10 950

Countries citing papers authored by Suzanne J. Randle

Since Specialization
Citations

This map shows the geographic impact of Suzanne J. Randle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne J. Randle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne J. Randle more than expected).

Fields of papers citing papers by Suzanne J. Randle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne J. Randle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne J. Randle. The network helps show where Suzanne J. Randle may publish in the future.

Co-authorship network of co-authors of Suzanne J. Randle

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne J. Randle. A scholar is included among the top collaborators of Suzanne J. Randle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne J. Randle. Suzanne J. Randle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, David B., Christos Kyprianou, Lucy R. O’Sullivan, et al.. (2022). Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors. Nature Communications. 13(1). 6021–6021. 4 indexed citations
2.
Wallez, Yann, Theresa A. Proia, Ankur Karmokar, et al.. (2022). Abstract 5298: Activity and tolerability of combinations of trastuzumab deruxtecan (T-DXd) with inhibitors of the DNA damage response in preclinical models. Cancer Research. 82(12_Supplement). 5298–5298. 1 indexed citations
3.
Harris, Rebecca, Suzanne J. Randle, & Heike Laman. (2021). Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells. Biochemical and Biophysical Research Communications. 554. 41–48. 4 indexed citations
4.
Randle, Suzanne J., Tycho E.T. Mevissen, Marcelo D. Gomes, et al.. (2020). The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway. Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(1). 129754–129754. 12 indexed citations
5.
Stott, Simon, Suzanne J. Randle, Sara Al Rawi, et al.. (2019). Loss of FBXO7 results in a Parkinson's‐like dopaminergic degeneration via an RPL23–MDM2–TP53 pathway. The Journal of Pathology. 249(2). 241–254. 22 indexed citations
6.
Randle, Suzanne J., Sara Al Rawi, Benjamin M. Skinner, et al.. (2019). A Conserved Requirement for Fbxo7 During Male Germ Cell Cytoplasmic Remodeling. Frontiers in Physiology. 10. 1278–1278. 15 indexed citations
7.
George‐Hyslop, Peter St, Julie Qiaojin Lin, Akinori Miyashita, et al.. (2018). The physiological and pathological biophysics of phase separation and gelation of RNA binding proteins in amyotrophic lateral sclerosis and fronto-temporal lobar degeneration. Brain Research. 1693(Pt A). 11–23. 54 indexed citations
8.
Randle, Suzanne J., et al.. (2016). Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27. Cellular and Molecular Life Sciences. 74(8). 1553–1566. 12 indexed citations
9.
Randle, Suzanne J. & Heike Laman. (2016). Structure and Function of Fbxo7/PARK15 in Parkinson's Disease. Current Protein and Peptide Science. 18(7). 715–724. 17 indexed citations
10.
Teixeira, Felipe R., Suzanne J. Randle, Tycho E.T. Mevissen, et al.. (2016). Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease. Biochemical Journal. 473(20). 3563–3580. 40 indexed citations
11.
Randle, Suzanne J. & Heike Laman. (2015). F-box protein interactions with the hallmark pathways in cancer. Seminars in Cancer Biology. 36. 3–17. 65 indexed citations
12.
Randle, Suzanne J., et al.. (2015). Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression. The Journal of Pathology. 237(2). 263–272. 20 indexed citations
13.
Burchell, Victoria, David E. Nelson, Álvaro Sánchez-Martínez, et al.. (2013). The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nature Neuroscience. 16(9). 1257–1265. 243 indexed citations
14.
Nelson, David E., Suzanne J. Randle, & Heike Laman. (2013). Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins. Open Biology. 3(10). 130131–130131. 71 indexed citations
15.
Lomonosov, Mikhail, et al.. (2011). Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis. PLoS ONE. 6(6). e21165–e21165. 20 indexed citations
16.
Randle, Suzanne J., et al.. (2011). Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells. Development. 138(14). e1–e1. 1 indexed citations
17.
Randle, Suzanne J., et al.. (2011). Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells. Journal of Cell Science. 124(13). 2175–2186. 35 indexed citations
18.
Salek, Reza M., Jing Xia, Amy Innes, et al.. (2010). A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochemistry International. 56(8). 937–947. 124 indexed citations
19.
Crook, Richard, Michael DeTure, Suzanne J. Randle, et al.. (2009). Overexpression of Wild-Type Murine Tau Results in Progressive Tauopathy and Neurodegeneration. American Journal Of Pathology. 175(4). 1598–1609. 51 indexed citations
20.
Kim, Jungsu, Luisa Onstead, Suzanne J. Randle, et al.. (2007). Aβ40 Inhibits Amyloid DepositionIn Vivo. Journal of Neuroscience. 27(3). 627–633. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prasad Tammineni Breakdown of academic impact, for papers by Natura Myeku Breakdown of academic impact, for papers by Mario Nizzari Breakdown of academic impact, for papers by Hyun Jin Cho Breakdown of academic impact, for papers by Misaki Sekiguchi Breakdown of academic impact, for papers by Seung Jae Hyeon Breakdown of academic impact, for papers by Julie Dunys Breakdown of academic impact, for papers by Pierre Dourlen Breakdown of academic impact, for papers by Chengyuan Mao Breakdown of academic impact, for papers by Heidi Martini‐Stoica
Rankless by CCL
2026